• Annual report 2024
  • Mijn verslag 0
    NS.nl

There are 292 results found

20. Accrued and deferred items

Accruals and deferred income as at 31 December 2023 amounted to €8 million (31 December 2022: €9 million).

2024 timetable: 1,800 additional trains

When the 2024 timetable takes effect, NS will run 1,800 additional trains per week. The new timetable is more aligned with the new travel behaviour of passengers since COVID-19.

21. Trade and other liabilities

Trade and other liabilities includes an amount of €29 million (2022: €24 million) relating to ProRail and the Dutch central government.

22. Deferred income

The deferred income of €590 million (2022: €565 million) consists mainly of amounts for student public transport passes received in advance and season ticket payments received in advance in the Netherlands.

23. Other financial assets, including investments

The interest in Eurofima is measured at fair value. The net asset value based on the most recently available financial statements of this interest has been used as the best approximation of the fair value.

24. Equity

See the consolidated statement of changes in equity for the movements in equity.

Page:
  • 1
  • 2
  • 3 (current page)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • Next page
  • Last page
Downloads
  • Annual Report 2024

  • Half-Year Report 2024 (new window)

  • Annual Report 2023

  • Annual Report 2022

  • Annual Report 2022

  • Annual Report 2021

  • Annual Report 2020

Contact
  • Contact (new window)

  • Corporate website (new window)

Archive
  • Website Annual Report 2023

  • Website Annual Report 2022 (new window)

  • Website Annual Report 2021 (new window)

  • Website Annual Report 2020 (new window)

  • Website Annual Report 2019 (new window)

About this website
  • Copyright

  • Colofon

  • Privacy

  • Cookies

  • Accessibility

  • Disclaimer (new window)

Social media
  • twitter
  • youtube
  • facebook
  • linkedin